Company Data
Pliant Therapeutics Inc.
Ticker
PLRX
Current Price
$1.27 -2.31%
Market Cap
$78.0M
Price Target
Refer to Report
Volume
507.1K
52wk Range
$1.09 - $3.46
Overview
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.